title: Re-transplantation after bortezomib-based therapy.
authors.forename: Curly
authors.initials: C
authors.lastname: Morris
authors.forename: Gordon
authors.initials: G
authors.lastname: Cook
authors.forename: Matthew
authors.initials: M
authors.lastname: Streetly
authors.forename: Paul
authors.initials: P
authors.lastname: Kettle
authors.forename: Mary
authors.initials: M
authors.lastname: Drake
authors.forename: Michael
authors.initials: M
authors.lastname: Quinn
authors.forename: Jim
authors.initials: J
authors.lastname: Cavet
authors.forename: Jane
authors.initials: J
authors.lastname: Tighe
authors.forename: Majit
authors.initials: M
authors.lastname: Kazmi
authors.forename: John
authors.initials: J
authors.lastname: Ashcroft
authors.forename: Mark
authors.initials: M
authors.lastname: Cook
authors.forename: John
authors.initials: J
authors.lastname: Snowden
authors.forename: Ade
authors.initials: A
authors.lastname: Olujohungbe
authors.forename: Scott
authors.initials: S
authors.lastname: Marshall
authors.forename: Jane
authors.initials: J
authors.lastname: Conn
authors.forename: Heather
authors.initials: H
authors.lastname: Oakervee
authors.forename: Rakesh
authors.initials: R
authors.lastname: Popat
authors.forename: Jamie
authors.initials: J
authors.lastname: Cavenagh
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage*; D001897:Boronic Acids / Q000008:administration & dosage*; D000069286:Bortezomib; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D009101:Multiple Myeloma / Q000628:therapy*; D011719:Pyrazines / Q000008:administration & dosage*; D012189:Retrospective Studies
chemical_list: D000970:Antineoplastic Agents; D001897:Boronic Acids; D011719:Pyrazines; D000069286:Bortezomib